The glaucoma treatments market is expected to increase to a value of US$ 6.9 million by 2022. Between 2022 and 2032, the total demand for glaucoma medicines is expected to grow at a compound annual growth rate (CAGR) of 3.7%, or approximately US$ 10.2 million. By treatment type, medication eye drops segment will hold the …